These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32658921)

  • 21. Implementation of human papillomavirus video education for women participating in mass cervical cancer screening in Tanzania.
    Cooper EC; Maher JA; Naaseh A; Crawford EW; Chinn JO; Runge AS; Lucas AN; Zezoff DC; Bera KR; Dinicu AI; White KM; Tewari SE; Hari A; Bernstein M; Chang J; Ziogas A; Pearre DC; Tewari KS
    Am J Obstet Gynecol; 2021 Jan; 224(1):105.e1-105.e9. PubMed ID: 32682861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acceptability and preferences for self-collected screening for cervical cancer within health systems in rural Uganda: A mixed-methods approach.
    Rawat A; Sanders C; Mithani N; Amuge C; Pedersen H; Namugosa R; Payne B; Mitchell-Foster S; Orem J; Ogilvie G; Nakisige C
    Int J Gynaecol Obstet; 2021 Jan; 152(1):103-111. PubMed ID: 33128778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knowledge, attitudes, and practices of cervical Cancer screening among HIV-positive and HIV-negative women participating in human papillomavirus screening in rural Zimbabwe.
    Fitzpatrick M; Pathipati MP; McCarty K; Rosenthal A; Katzenstein D; Chirenje ZM; Pinsky B
    BMC Womens Health; 2020 Jul; 20(1):153. PubMed ID: 32711530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increasing Referral Acceptance for Women's Health Services Among Hispanic Women.
    Gale A
    Nurs Womens Health; 2024 Aug; 28(4):296-302. PubMed ID: 38761817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
    Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical cancer screening by high risk HPV testing in routine practice: results at one year recall of high risk HPV-positive and cytology-negative women.
    Del Mistro A; Frayle H; Ferro A; Callegaro S; Del Sole A; Stomeo A; Cirillo E; Fedato C; Pagni S; Barzon L; Zorzi M;
    J Med Screen; 2014 Mar; 21(1):30-7. PubMed ID: 24488593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of text message reminders on cryotherapy uptake among women testing positive for HPV in western Kenya: a prospective cohort study.
    Choi Y; Ibrahim S; Park LP; Bukusi EA; Huchko MJ
    BMC Womens Health; 2024 Jan; 24(1):32. PubMed ID: 38218782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Peru Cervical Cancer Prevention Study (PERCAPS): the technology to make screening accessible.
    Levinson KL; Abuelo C; Salmeron J; Chyung E; Zou J; Belinson SE; Wang G; Ortiz CS; Vallejos CS; Belinson JL
    Gynecol Oncol; 2013 May; 129(2):318-23. PubMed ID: 23385153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mobile Phone Ownership and Use Among Women Screening for Cervical Cancer in a Community-Based Setting in Western Kenya: Observational Study.
    Stocks J; Ibrahim S; Park L; Huchko M
    JMIR Public Health Surveill; 2022 Jun; 8(6):e28885. PubMed ID: 35671089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical cancer screening in rural Ethiopia: a cross- sectional knowledge, attitude and practice study.
    Ruddies F; Gizaw M; Teka B; Thies S; Wienke A; Kaufmann AM; Abebe T; Addissie A; Kantelhardt EJ
    BMC Cancer; 2020 Jun; 20(1):563. PubMed ID: 32552740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada.
    Vahabi M; Lofters A
    BMC Public Health; 2016 Aug; 16(1):868. PubMed ID: 27557928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factors.
    Rodrigues LLS; Morgado MG; Sahasrabuddhe VV; De Paula VS; Oliveira NS; Chavez-Juan E; Da Silva DM; Kast WM; Nicol AF; Pilotto JH
    Gynecol Oncol; 2018 Oct; 151(1):102-110. PubMed ID: 30087059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial.
    Denny L; Kuhn L; De Souza M; Pollack AE; Dupree W; Wright TC
    JAMA; 2005 Nov; 294(17):2173-81. PubMed ID: 16264158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biopsychosocial risk factors and knowledge of cervical cancer among young women: A case study from Kenya to inform HPV prevention in Sub-Saharan Africa.
    Ngune I; Kalembo F; Loessl B; Kivuti-Bitok LW
    PLoS One; 2020; 15(8):e0237745. PubMed ID: 32817627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Provider-Identified Barriers to Cervical Cancer Screening and Perceptions Toward Self-Collection of Human Papillomavirus in Southwest Virginia.
    Garcia C; Lothamer H; Mitchell EM
    Public Health Nurs; 2016 Nov; 33(6):539-546. PubMed ID: 27444141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-label, Randomized Clinical Trial.
    Zhang J; Zhao Y; Dai Y; Dang L; Ma L; Yang C; Li Y; Kong L; Wei L; Zhang S; Liu J; Xi M; Chen L; Duan X; Xiao Q; Abulizi G; Zhang G; Hong Y; Gao X; Zhou Q; Xie X; Li L; Niyazi M; Zhang Z; Tuo J; Ding Y; Si M; Chen F; Song L; Qiao Y; Lang J
    JAMA Oncol; 2021 Feb; 7(2):263-270. PubMed ID: 33377903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women.
    Kuhn L; Wang C; Tsai WY; Wright TC; Denny L
    AIDS; 2010 Oct; 24(16):2553-61. PubMed ID: 20706107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Papillomavirus and Cervical Cancer Knowledge, Perceptions, and Screening Behavior: A Cross-Sectional Community-Based Survey in Rural Philippines.
    Imoto A; Honda S; Llamas-Clark EF
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3145-3151. PubMed ID: 33247669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.